Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. (Q53582013)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 November 2006

Language	Label	Description	Also known as
English	Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation.	scientific article published on 14 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

reactive oxygen species

1 reference

based on heuristic

inferred from title

author name string

Utako Kaneyuki

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Seiji Ueda

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Sho-ichi Yamagishi

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Seiya Kato

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Toshiko Fujimura

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Ryo Shibata

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Ayako Hayashida

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Junko Yoshimura

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Masamichi Kojiro

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Koichi Oshima

10

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Seiya Okuda

11

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

publication date

14 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

46

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

286-292

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Current molecular models for NADPH oxidase regulation by Rac GTPase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Vascular NADPH oxidases: molecular mechanisms of activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Cellular adhesion molecules on vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Regulation of mitogen-activated protein kinase cascades by low density lipoprotein and lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Role of oxidative stress in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophospholipids and the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophosphatidic acid synthesis and release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Plaque rupture, lysophosphatidic acid, and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Calcitonin receptor isoforms expressed in the developing rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Cellular antioxidant effects of atorvastatin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VPH.2006.11.002

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53582013&oldid=1768524948"